Vericel Corporation | Advanced cell therapies
Description: NexoBrid® (anacaulase-bcdb) is an effective and selective enzymatic agent that removes eschar in adults while preserving viable tissue
By continuing to use this website, you consent to our use of cookies and the other terms of our Privacy Policy. For more information, please visit our Privacy Policy .
Accept and Close
This site is intended for U.S. healthcare professionals only.
Vericel Corporation | Advanced cell therapies